Immunologic Aspects of the Hematologic Neoplasms

REFERENCES

• Burnet FM: Immunological surveillance in neoplasia. Transplant Rev 7:3–25, 1971
   PubMedGoogle Scholar
• Fraumeni JF Jr: Constitutional disorders of man predisposing to leukemia and lymphoma. Natl Cancer Inst Monogr 32:221–232, 1969
   PubMedGoogle Scholar
• Pierce JC, Madge GE, Lee HM, et al: Lymphoma, a complication of renal allotransplantation in man. JAMA 219:1593–1597, 1972
   PubMed Web of Science ®Google Scholar
• Forbes JF, Morris PJ: Leucocyte antigens in Hodgkin's disease. Lancet 2:849–951, 1970
   PubMed Web of Science ®Google Scholar
• Forbes JF, Morris PJ: Transplantation antigens and malignant lymphomas in man. Tissue Antigens 1:265–269, 1971
   PubMedGoogle Scholar
• Durie BGM, Taswell HF: HLA antigens in myelomonocytic leukemia. Transplantation (in press)
   Google Scholar
• Lilly F: H-2, membranes and viral leukemogenesis. In Cohen S, Cudkowicz G, McCuskey RT (Editors): Proceedings of Second International Convocation on Immunology (Buffalo, 1970). Basel, Switzerland, S Karger, 1971, p 103
   Google Scholar
• McDevitt HO, Bodmer WF: Histocompatibility antigens, immune responsiveness and susceptibility to disease. Am J Med 52:1–8, 1972
   PubMed Web of Science ®Google Scholar
• Schwartz RS: Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet 1:1266–1269, 1972
   PubMed Web of Science ®Google Scholar
• Chase MW: Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis. Cancer Res 26:1097–1120, 1966
   PubMed Web of Science ®Google Scholar
• Ewing J: Neoplastic Diseases. Philadelphia, WB Saunders Company, 1928
   Google Scholar
• Kaplan HS: Hodgkin's Disease. Cambridge, Mass, Harvard University Press, 1972, pp 184–195
   Google Scholar
• Sokal JE, Aungst CW: Response to BCG vaccination and survival in advanced Hodgkin's disease. Cancer 24:128–134, 1969
   PubMed Web of Science ®Google Scholar
• Aisenberg AC: Updated Hodgkin's disease. Value of immunologic testing. JAMA 222:1301–1302, 1972
   Google Scholar
• Young RC, Corder MP, Berard CW, et al: Immune alterations in Hodgkin's disease. Arch Intern Med 131:446–454, 1973
   PubMedGoogle Scholar
• Keller AR, Kaplan HS, Lukes RJ, et al: Correlation of histopathology with other prognostic indicators in Hodgkin's disease. Cancer 22:487–499, 1968
   PubMed Web of Science ®Google Scholar
• Order SE, Hellman S: Tumor-associated antigens. A new perspective of Hodgkin's disease. JAMA 223:174–175, 1973
   Google Scholar
• Sokal JE, Primikirios N: The delayed skin test response in Hodgkin's disease and lymphosarcoma. Effect of disease activity. Cancer 14:597–607, 1961
   Web of Science ®Google Scholar
• Piessens WF, Schur PH, Maloney WC, et al: Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med 288:176–180, 1973
   PubMed Web of Science ®Google Scholar
• Moore DF, Migliore PJ, Shullenberger CC, et al: Monoclonal macroglobulinemia in malignant lymphoma. Ann Intern Med 72:43–47, 1970
   PubMed Web of Science ®Google Scholar
• Jones SE: Autoimmune disorders and malignant lymphoma. Cancer 31:1092–1098, 1973
   PubMed Web of Science ®Google Scholar
• Harris F: Leukemia antigens and immunity in man. Nature 241:95–100, 1973
   PubMed Web of Science ®Google Scholar
• Metzgar RS, Mohanakumar T, Miller DS: Antigens specific for human lymphocytic and myeloid leukemia cells: Detection by nonhuman primate antiserums. Science 178:986–988, 1972
   PubMed Web of Science ®Google Scholar
• Halterman RH, Leventhal BG, Mann DL: An acute-leukemia antigen: Correlation with clinical status. N Engl J Med 287:1272–1274, 1972
   PubMed Web of Science ®Google Scholar
• Gutterman JU, Hersh EM, McCredie KB, et al: Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence and prognosis. Cancer Res 32:2524–2529, 1972
   PubMed Web of Science ®Google Scholar
• Baxt W, Hehlmann R, Spiegelman S: Human leukaemic cells contain reverse transcriptase associated with a high molecular weight virus-related RNA. Nature [New Biol] 240:72–75, 1972
   Web of Science ®Google Scholar
• Bekesi JG, St Arneault G, Walter L, et al: Immunogenicity of leukemia L1210 cells after neuraminidase treatment. J Natl Cancer Inst 49:107–118, 1972
   PubMedGoogle Scholar
• Durie BGM, Taswell HF: Mixed lymphocyte cultures in patients with myelomonocytic leukemia. In Abstracts of the Proceedings of American Society of Hematology, 15th Annual Meeting (December 1972), p 141
   Google Scholar
• Gutterman JU, Rossen RD, Butler WT, et al: Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med 288:169–175, 1973
   PubMed Web of Science ®Google Scholar
• Salmon SE: Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin Hematol 10: 135, 1973
   PubMed Web of Science ®Google Scholar
• Salmon SE: “Paraneoplastic” syndromes associated with monoclonal lymphocyte and plasma cell proliferation. Ann NY Acad Sci (in press)
   Google Scholar
• Potter M: Myeloma proteins (M-components) with antibody-like activity. N Engl J Med 284:831–838, 1971
   PubMed Web of Science ®Google Scholar
• Potter M: The plasma cell tumors and myeloma proteins of mice. In Busch H (Editor): Methods in Cancer Research. New York, Academic Press Inc, 1967, vol 2, pp 105–107
   Google Scholar
• Glenner GG, Terry W, Harada M, et al: Amyloid fibril proteins: Proof of homology with immunoglobulin light chains by sequence analyses. Science 172:1150–1151, 1971
   PubMed Web of Science ®Google Scholar
• Fahey JL, Scoggins R, Utz JP, et al: Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia. Am J Med 35:698–707, 1963
   PubMed Web of Science ®Google Scholar
• Salmon SE, Fudenberg HH: Abnormal nucleic acid metabolism of lymphocytes in plasma cell myeloma and macroglobulinemia. Blood 33:300–312, Feb 1969
   PubMed Web of Science ®Google Scholar
• Salmon SE, Samal BA, Hayes DM, et al: Role of gamma globulin for immunoprophylaxis in multiple myeloma. N Engl J Med 277:1336–1340, 1967
   PubMed Web of Science ®Google Scholar
• Lindstrom FD, Hardy WR, Eberle BJ, et al: Multiple myeloma and benign monoclonal gammopathy: Differentiation by immunofluorescence of lymphocytes. Ann Intern Med 78:837–844, 1973
   PubMed Web of Science ®Google Scholar
• Linton AL, Dunnigan MG, Thomson JA: Immune responses in myeloma. Br Med J 5349:86–89, 1963
   Google Scholar
• Waldmann TA, Strober W: Metabolism of immunoglobulins. Progr Allergy 13:1–110, 1969
   PubMedGoogle Scholar